- Author:Maggie Kolb
Dr. Might’s passion has been accelerating the promise of precision medicine for patients since 2012, when his son was diagnosed via sequencing as the first known case of NGLY1 deficiency. Dr. Might is currently a Visiting Associate Professor in Biomedical Informatics at the Harvard Medical School. He has been actively engaged with White House and NIH leadership on the Precision Medicine Initiative, serving as an ardent advocate for translational science in the initiative. Dr. Might is also an Associate Professor in Computer Science at the University of Utah. His work is actively funded by DARPA, NSF and the National Nuclear Security Administration. In 2014, he was appointed one of six Presidential Scholars at the University of Utah. He received his Ph.D. in Computer Science from Georgia Tech in 2007.